chr1-159062696-GT-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM4BP6BS2
The NM_004833.3(AIM2):c.1027del(p.Thr343HisfsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00443 in 1,390,226 control chromosomes in the GnomAD database, including 15 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0029 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 12 hom. )
Consequence
AIM2
NM_004833.3 frameshift
NM_004833.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0140
Genes affected
AIM2 (HGNC:357): (absent in melanoma 2) AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Frameshift in the end of transcript resulting in stoplost. Downstream stopcodon found after 439 codons.
BP6
Variant 1-159062696-GT-G is Benign according to our data. Variant chr1-159062696-GT-G is described in ClinVar as [Benign]. Clinvar id is 3041346.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIM2 | NM_004833.3 | c.1027del | p.Thr343HisfsTer14 | frameshift_variant | 6/6 | ENST00000368130.9 | NP_004824.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIM2 | ENST00000368130.9 | c.1027del | p.Thr343HisfsTer14 | frameshift_variant | 6/6 | 1 | NM_004833.3 | ENSP00000357112 | P1 | |
AIM2 | ENST00000411768.2 | c.1027del | p.Thr343HisfsTer14 | frameshift_variant | 9/9 | 5 | ENSP00000512039 | P1 | ||
AIM2 | ENST00000695580.1 | c.1027del | p.Thr343HisfsTer14 | frameshift_variant | 7/7 | ENSP00000512040 | P1 | |||
AIM2 | ENST00000695579.1 | c.616del | p.Thr206HisfsTer14 | frameshift_variant | 5/5 | ENSP00000512038 |
Frequencies
GnomAD3 genomes AF: 0.00290 AC: 428AN: 147422Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
428
AN:
147422
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00461 AC: 5727AN: 1242724Hom.: 12 Cov.: 31 AF XY: 0.00454 AC XY: 2813AN XY: 619522
GnomAD4 exome
AF:
AC:
5727
AN:
1242724
Hom.:
Cov.:
31
AF XY:
AC XY:
2813
AN XY:
619522
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00291 AC: 429AN: 147502Hom.: 3 Cov.: 32 AF XY: 0.00284 AC XY: 204AN XY: 71742
GnomAD4 genome
AF:
AC:
429
AN:
147502
Hom.:
Cov.:
32
AF XY:
AC XY:
204
AN XY:
71742
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
AIM2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 12, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at